MGTX Overview
Upcoming Projects (MGTX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (MGTX)
-
A Second Opinion: Reviewing the potential of AAV-GAD, a gene therapy from MeiraGTx for the treatment of Parkinson's Disease
Ticker: MGTX
Executed On: Nov 07, 2024 at 03:00 PM EST -
Reviewing the potential of AAV-GAD, a gene therapy from MeiraGTx for the treatment of Parkinson's Disease
Ticker: MGTX
Executed On: Oct 25, 2024 at 03:00 PM EDT
Expired Projects (MGTX)
-
Analyzing MeiraGTx’s AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
Ticker: MGTX
Execute By: Feb 18, 2022
Upcoming & Overdue Catalysts (MGTX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (MGTX)
-
Nine-Month Data Released from MeiraGTx (MGTX) and J&J (JNJ) Phase 1/2 Trial of AAV-RPGR in X-Linked Retinitis Pigmentosa (XLRP)
Tickers: MGTX, JNJ
Occurred on: Oct 03, 2020
Strategic Initiatives (MGTX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
